Revive MD Brain+: A Whole Brain Health Nootropic Supplement
Run by Dr. Domenic Iacovone and elite fitness trainer Matt Jansen, Revive MD has shaken up the sports supplement industry with issue-specific health formulas that bring incredible clinical dosages. Some prime examples are Revive MD Lipid, Heart, and Prostate. The line is targeted towards high-end athletes, and early on in their career, most other brands in the industry ignored or downplayed the idea, continuing short-termed focus on pre workout supplements and candy flavoring.
Yet, Revive MD’s monstrous success showed that high-end athletes do care about their whole body health and not just their looks or performance. With the brand’s rise, we’re now seeing those same naysayers copy Jansen and Iacovone’s model and formulas left and right.
This time, however, Team Revive is taking a page out of the industry’s playbook – developing a nootropic supplement meant to improve cognitive performance – but they’re bringing their whole health ethos into the fold.
Revive MD Brain: A new look at whole brain health
With formulas like Heart and Prostate, it was only a matter of time before the BRAIN became a focus. Revive MD is making the Brain+ nootropic their way — by focusing on whole brain health and cognitive function.
A brain health nootropic with lithium?! Get in here!
On top of standby favorites like choline, carnitine, phosphatidylserine, and tyrosine, Brain+ adds some punch from Rhodiola rosea and a high-quality blend of B-vitamins (the good ones)… and even has some lithium added!
It’s stimulant-free to boot.
There’s even more than that, so we dig deep into the label below, but first, make sure you check our coupon-backed prices and sign up for PricePlow’s Revive MD alerts, they’ve got far more on the horizon:
Revive MD Brain+ – Deals and Price Drop Alerts
Get Price Alerts
No spam, no scams.
Disclosure: PricePlow relies on pricing from stores with which we have a business relationship. We work hard to keep pricing current, but you may find a better offer.
Posts are sponsored in part by the retailers and/or brands listed on this page.
Revive MD BRAIN+ Ingredients
Get ready to pound through ten sets of ingredients in Brain+, all of which come in four capsules. There’s no caffeine, so you can stack with your coffee, energy drink, fat burner, or pre workout.. or just take them solo.
In the article, we’re going to combine the B-vitamins in their own area, and the two choline sources as well.
The first thing to recognize on this label is that the B-Vitamins are from quality sources.
P5P over Pyridoxine!
For instance, we have Vitamin B6 from Pyridoxal-5-Phosphate (P5P), as opposed to pyridoxine — the latter of which can be oversaturated and cause severe sensory neuropathy. Cheaper pyridoxine actually inhibits B6-dependent enzymes within the body, ultimately limiting absorption! P5P (pyridoxal-5′-phosphate or PLP), on the other hand, is the form of vitamin B6 that the body actually uses – this form of vitamin B6 leads to energy conversion, metabolic functioning, and neurotransmitter signaling. It’s readily dephosphorylated and easily absorbed.
Long story short – cheaper vitamins may actually reduce your ability to process said vitamins – and that’s not good for the brain. Not here with Brain+.
At 20mg (1176% recommended daily value), your vitamin B6 should be well-covered for the day.
Active Folate Source in 5-MTHF
Similarly, for our folate source (something most brain health supplements don’t provide at all), we have L-5-methyltetrahydrofolate (5-MTHF) rather than folic acid. Folate is critically important for DNA synthesis and repair, cell division, red blood cell maturation, and homocysteine / methionine conversion. Like P5P above, 5-MTHF is the active form used in the body.
The issue with standard folic acid supplementation is that it requires the methylenetetrahydrofolate reductase (MTHFR) enzyme that converts folic acid to 5-MTHF. Genetically, however, not everyone has the ability to convert great amounts of it.[6,7] This can lead to methylation issues or folate deficiencies (alongside lower SAMe levels and too much homocysteine), causing numerous issues – cognitive and otherwise. The solution is to use the active form – 5-methyltetrahydrofolate – like Revive MD is here.
Note that this is a 50% daily value dosage, so hopefully you’re getting more folate elsewhere in your day.
Methylcobalamin as the Vitamin B12 Source
Once again, Revive opted for a better vitamin source – in this case, we’re getting Vitamin B12 from Methylcobalamin. Here, we have a vitamin bound to a methyl group as opposed to a cyanide group in the cheaper alternative, cyanocobalamin, which is often seen on other supplement labels. When looking at multivitamins, the Vitamin B12 source is our first litmus test – and even though Revive MD Brain+ isn’t a multi, it definitely passes the test by skipping the cheap ingredients and using quality compounds.
With B12 supplementation, we’re trying to avoid deficiency, which can lead to cognitive impairment, depression, neurological issues, anemia, and hyper-homocysteinemia. Research has demonstrated that given the complementary functions of vitamin B12 and folate, it’s smart to take them together, as we are here.
Worth noting that we have a smashing 500mcg dose worth 20,833% minimum daily value – there shouldn’t be any B12 deficiency anytime with Brain+ users!
Finally, we have a solid 100mg dose of Niacin, which is 625% daily value. There are several uses for niacin in the body, yielding numerous metabolic benefits when supplemented to avoid deficiency. But in terms of cognition, we’re looking at how it is used as a substrate for NAD+ production, yielding improved energy states. It’s also used to prevent age-related decline, although that line of research requires more data.
Mitochondrial health will become a persistent issue on the Brain+ label, as you’ll see with other ingredients like PQQ and ALCAR.
Lithium (as lithium orotate, yielding 400mcg)
This is the first time we’ve covered lithium added to a nootropic supplement, but it’s here for a great reason. Many may think of this as being used as an antipsychotic drug, but in this form, it’s not even a drug. Lithium is simply a mineral – and an essential one at that. The long story short is that lithium is a mood stabilizer.
Lithium is found in fish, meat, dairy products, eggs, tubers, and other vegetables. Daily intake is generally 2 – 600 micrograms, depending on diet and locale.
It was first discovered to treat psychosis in 1949, and in 1970, the US FDA approved high dose lithium carbonate and lithium citrate as prescription drugs to treat bipolar disorder, with several successful clinical trials on those drugs over the past several decades.
There is fascinating research covering lithium and its deficiency – for instance, a study conducted on 27 Texas counties from 1978-1987 found that counties whose water supply contained little or no lithium had significantly higher rates of suicide, drug addiction, and violent crimes! This was further demonstrated in 2013, once again in Texas — less lithium in the water correlated to more suicide.
A similar study in Japan also showed that greater lithium levels in the water led to less suicide, and other research from Japan has led researchers to conclude that low-dose lithium uptake promotes longevity in humans and metazoans, which is actually the title of the paper.
Lithium supplementation in former drug addicts and alcoholics not only significantly prevents relapse, but it also improves overall mood, energy, and levels of happiness and friendliness in such populations.[18,19]
Data like the above, as well as several meta-analyses, led researchers to hypothesize that low levels should be given to the general population in all drinking water, but that is obviously controversial, and most readers would prefer to supplement it themselves.
How does lithium work?
Recent research has shown that lithium inhibits glycogen synthase kinase-3β (GSK-3β), and with that, we see an upregulation of brain-derived neurotrophic factor (BDNF) and IGF-1, the former of which stimulates new neuron production in the hippocampus. GSK-3β inhibition yields anti-depressive behavior in rats, so pointing to this mechanism seems to be on the right track.
The mineral also increases the brain’s production of bcl-2, a neuroprotective protein, and that is something that most (if not all) medications cannot do.
This means that we not only see a prevention of neuronal cell death, but improved neuron production with adequate amounts of lithium!
However, without getting your water and food tested, you may not know if you’re getting enough. 400mcg of lithium orotate is a nice low dose for beginners. We see supplements at far higher doses, but for those new to taking this mineral, this is a good place to begin.
Now, on to the active ingredients in Revive MD Brain+:
Choline Blend: 600mg Alpha-GPC 50% and 250mg Citicoline
BRAIN+ has a fantastic blend of two sources of choline – and they’re the two highest-bioavailability sources at that! We have a clinical dose of 600mg Alpha-GPC combined with an additionally impressive 250mg citicoline.
Choline is critically required to help maintain structural integrity of cell membranes, and is also a precursor to other compounds in the body. One compound is actually a neurotransmitter called acetylcholine, and it’s dubbed the “learning neurotransmitter” due to its importance in the brain’s synaptic system and high involvement in cell-to-cell communication (it’s found in high concentrations in neuromuscular junctions).
Acetylcholine thus improves coordination, balance, memory, learning, attention/alertness, and even a “mind-muscle connection” when working out.[26,27]
Choline deficiency is on the rise, and with that comes major health issues such as fatty liver disease, organ/muscle damage, and general brain fog.
The solution, outside of the obvious one of eating more meat, fish, and eggs, is to supplement. The two highest-bioavailability forms on the market are in MD BRAIN+ – Alpha-GPC and Citicoline. We often are pressed to choose one over the other when looking at choline-based supplements… Revive MD makes that easy by including both.
Alpha-GPC: Crossing the blood brain barrier
Scientifically known as alpha-glycerylphosphorylcholine, a highly-bioavailable form that can be quickly absorbed, Alpha-GPC can cross the blood brain barrier, helping to synthesize more acetylcholine after its conversion to phosphorylcholine. In recent years, a lot of research has shown it increasing not just cognition, but also power and performance – and at the doses included in BRAIN+![30-33]
Citicoline: increased norepinephrine and dopamine levels
Meanwhile, citicoline, also known as Cytidine 5′-Diphosphocholine and CDP-Choline, has some tricks of its own beyond acetylcholine production support. Citicoline can increase norepinephrine and dopamine levels, and even boosts dopamine receptor density.
Overall, this blend is fantastic, and we’re very confident that most users would be feeling this mix on its own, let alone all the other ingredients inside!
Acetyl L-Carnitine – 500mg
We often see various forms of carnitine in fat burners, as it helps with fatty acid transport to the mitochondria, the cell’s “powerhouses”. You can’t burn it if you can’t transport it, after all. Carnitine is found in meat, so similar to the choline sources above, the best results will come in vegans and vegetarians.[36,37]
This is great, but why in a nootropic? Because the additional acetyl group in Acetyl L-Carnitine enables it to cross the blood brain barrier! ALCAR can thus increase focus, boost memory recall, and provide some neuroprotection.[39-41]
Anecdotally speaking, 500mg is just on the lower end of where we start “feeling” it. Many of the athletic-minded studies dose it at 2g/day, so if you’re an aggressive Revive MD style athlete, eat your meat and even consider a bit more for more recovery!
L-Tyrosine – 500mg
L-tyrosine is an amino acid that functions as a precursor to several of our favorite neurotransmitters like norepinephrine, epinephrine, and dopamine.
When levels of catecholamine neurotransmitters – specifically norepinephrine – are too low, we generally have impaired cognitive and physical performance. However, supplementing L-tyrosine in stressful situations can increase production and help cellular firing, improving performance.
Several studies have shown that L-tyrosine increases plasma tyrosine levels better than alternative forms, so it’s great to see Revive MD using it. Similar to ALCAR, 500mg is the dose where we anecdotally begin feeling it, although we’ve seen pre workout supplements with far more.
Rhodiola Rosea (root) Extract (std to 3% rosavins, 1% salidrosides) – 300mg
Our favorite herb, Rhodiola rosea is a phenomenal adaptogen that gets key brain chemistry levels in proper order. It functions on serotonin, and several research studies have shown it lead to improved mood states.
Mechanistically, Rhodiola seems to spike long-term potentiation (LTP) of synaptic transmission in the hippocampus, generating its interest for use in nootropics. The effects actually began working at the given standardization as well – 3% rosavins and 1% salidrosides.
In just 14 days, 200 milligrams of Rhodiola rosea extract (less than what we have here) saw significant reductions in anxiety, stress, anger, confusion, and depression, with overall mood improvements reported. Another study on 101 subjects taking 200 milligrams twice per day reported reduced stress, and it began working within three days of taking it!
For the Revive warriors out there, Rhodiola reduces both mental and physical fatigue at both lower doses (100mg for 20 days) and higher doses (370mg or 555mg).
Note that Rhodiola functions as an MAO inhibitor,[53,54] and should not be combined with pharmaceutical drugs such as SSRIs, although the dopamine-prolonging effect is generally great for those of us not on such drugs.
We’ve long believed that more nootropics should have Rhodiola, and here it is in BRAIN+. We detail these studies, the mechanism, and far more about this fantastic herb in our article titled Rhodiola: The Salidroside-Powered Adaptogen of the Vikings.
Alpha Lipoic Acid – 250mg
Alpha Lipoic Acid (ALA) is an organosulfur compound that’s essential for proper functioning of aerobic metabolism. We see supplements include ALA for various reasons, but it’s most often used for its antioxidant effects and support in blood sugar and aging control.
However, it’s about time we saw a solid dose in a nootropic, because there are cognitive benefits as well!
Improved glutathione (antioxidant) status in neurons
First, ALA enhances glutamine production through the enzymatic activity of glutamine synthetase in astrocytes, and helps them take more glutamine in.[56,57] Because of its ability to nudge glutamine levels up, ALA improves glutathione levels in neurons by 40%. The neurons use this glutathione to fight “neurotoxic events”, especially glutamate excitotoxicity, a state where too much glutamate overstimulates cells and causes long term damage.
With this mechanism, ALA has been shown to protect against conditions like seizures and cyanide toxicity.[58,59]
Choline, Dopamine, Norepinephrine, and Nerve Recovery!
Even better, ALA may enhance the reuptake of acetylcholine in a similar fashion. Low-dose ALA boosted dopamine and norepinephrine levels in the hippocampus by roughly 10% in one trial.
So while we don’t see it in nootropics a lot, the blood sugar protection alone is worth a look (less blood sugar “rollercoasting” leads us to improved long-term focus), but the synergy with our choline blend makes it even more appealing inside.
You can also find ALA in Revive MD’s Glucose supplement.
Phosphatidylserine (as Sharp PS Green) – 100mg
Phosphatidylserine is a fat-soluble amino acid mostly found in the brain that helps support cognitive function. Many research studies have shown that consuming it helps to prevent symptoms of declining mental function and even depression in elderly populations.[61-64]
Beyond that, there are studies showing it’s effective at decreasing stress and anxiety. At high enough doses greater than what we have here, it can reduce cortisol levels.
For the Revive MD athletes out there, it gets better: some research has shown that phosphatidylserine may improve exercise endurance for athletes, but that was again at higher doses. Something for the endurance athletes to look into, though.
Saffron (Stigma and Style) – 30mg
Another unique addition to Revive MD Brain+ is saffron (scientifically known as Crocus Sativus L.), which is most often used in the supplement world due to its appetite suppressing effects. This is similar for Rhodiola, listed above, both of which improve serotonin levels in the body.
As such, there has been an incredible amount of research with regards to saffron decreasing symptoms of depression, and most studies are at this 30mg dose![69-73]
These effects lead us to understand how it’s successful in appetite suppression (although we’d still always argue for a more nutrient-dense diet), but lead us to believe that it’s better suited in a brain health supplement that targets overall brain health – exactly what we’re taking here.
Pyrroloquinoline Quinone (as PQQ Disodium Salt) – 10mg
Known as PQQ, this small molecule does several incredible things in the body, and while it’s often touted as an anti-aging mitochondrial booster, it’s the cognitive health effects that deserve more attention. Research has shown that PQQ increases cerebral blood flow and oxygen metabolism, resulting in enhanced cognitive function.
PQQ works by helping you generate more energy via mitochondrial biogenesis activation. This means that it can help you create more mitochondria – and that improves brain health as well as muscle and metabolic function!
This leads to a form of “clean energy” that you don’t get with stimulants – and it has been shown to decrease fatigue and lower stress while it does so.
We don’t see it often enough because it’s not the cheapest ingredient, but any Revive MD fan knows that the brand spares no expense when it comes to working ingredients.
Revive MD suggests taking 4 capsules per day. We’d generally recommend this in the morning, but some may want to test taking 2 in the morning and 2 mid-afternoon before the “slump”. This will help space out the ingredients and bring some potential sleep improvements to boot.
Revive MD educates the market… again
Now that’s what we call a brain health supplement. You may have come here expecting a “nootropic” geared towards cognitive focus. Those benefits are great, and they’re included in this supplement, but there’s also so much more.
On top of straight “focus”, we also have mood enhancement, stress support, deficiency protection, and prevention against cognitive decline. One of the best things to pair with this, on top of any organ-specific supplements you like from the brand, could simply be the Revive MD Omega-3 supplement. Those looking to hit the anti-anxiety angle harder may also enjoy Revive MD Calm. There’s not much else here that isn’t covered in terms of getting your brain back on track.
Nootropic “newcomers” in saffron and lithium meet our “standard” ingredients in choline and carnitine, and with the help of Rhodiola and some others, Revive MD BRAIN+ should be unlike anything you’ve felt in a cognitive supplement ever. Sign us up.
Revive MD Brain+ – Deals and Price Drop Alerts
Get Price Alerts
No spam, no scams.
Disclosure: PricePlow relies on pricing from stores with which we have a business relationship. We work hard to keep pricing current, but you may find a better offer.
Posts are sponsored in part by the retailers and/or brands listed on this page.
- Schaumburg, H, et al; “Sensory Neuropathy from Pyridoxine Abuse. A New Megavitamin Syndrome”; The New England Journal of Medicine; U.S. National Library of Medicine; 25 Aug. 1983; https://pubmed.ncbi.nlm.nih.gov/6308447
- Ebadi, M, et al; “Hippocampal Zinc Thionein and Pyridoxal Phosphate Modulate Synaptic Functions.”; Departments of Pharmacology and Neurology, University of Nebraska College of Medicine; 1990; https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.1990.tb28053.x
- McCormick D. Vitamin B6. In: Bowman B, Russell R, eds. Present Knowledge in Nutrition. 9th ed. Washington, DC: International Life Sciences Institute; 2006; https://www.scirp.org/(S(i43dyn45teexjx455qlt3d2q))/reference/ReferencesPapers.aspx?ReferenceID=559786
- Revuelta, José Luis et al. “Formation of folates by microorganisms: towards the biotechnological production of this vitamin.” Applied microbiology and biotechnology vol. 102,20 (2018): 8613-8620. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153639/
- Verhaar, M. C., et al. “5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia.” Circulation, vol. 97, no. 3, 27 Jan. 1998, pp. 237–241, 10.1161/01.cir.97.3.237; https://pubmed.ncbi.nlm.nih.gov/9462523/
- Gilbody, S., et al. “Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review.” American Journal of Epidemiology, vol. 165, no. 1, 13 Oct. 2006, pp. 1–13, 10.1093/aje/kwj347; https://academic.oup.com/aje/article/165/1/1/232658
- Sharp, Linda, and Julian Little. “Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: A HuGE Review.” American Journal of Epidemiology, vol. 159, no. 5, 1 Mar. 2004, pp. 423–443; 10.1093/aje/kwh066; https://academic.oup.com/aje/article/159/5/423/92121
- Ryan-Harshman, M, and Aldoori, W. “Vitamin B12 and health.” Canadian family physician Medecin de famille canadien vol. 54,4 (2008): 536-41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2294088/
- Sauve, A. A. “NAD+ and Vitamin B3: From Metabolism to Therapies.” Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 3, 19 Dec. 2007, pp. 883–893, 10.1124/jpet.107.120758; https://pubmed.ncbi.nlm.nih.gov/18165311/
- Alisky, Joseph Martin. “Niacin Improved Rigidity and Bradykinesia in a Parkinson’s Disease Patient but Also Caused Unacceptable Nightmares and Skin Rash–a Case Report.” Nutritional Neuroscience, vol. 8, no. 5-6, 1 Oct. 2005, pp. 327–329, 10.1080/10284150500484638; https://pubmed.ncbi.nlm.nih.gov/16669604/
- Schrauzer, Gerhard N. “Lithium: Occurrence, Dietary Intakes, Nutritional Essentiality.” Journal of the American College of Nutrition, vol. 21, no. 1, 1 Feb. 2002, pp. 14–21, 10.1080/07315724.2002.10719188; https://pubmed.ncbi.nlm.nih.gov/11838882/
- Cade, J. F. “Lithium Salts in the Treatment of Psychotic Excitement. 1949.” Bulletin of the World Health Organization, vol. 78, no. 4, 2000, pp. 518–520; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2560740/pdf/10885180.pdf
- Bauer, Michael, et al. “Role of Lithium Augmentation in the Management of Major Depressive Disorder.” CNS Drugs, vol. 28, no. 4, 5 Mar. 2014, pp. 331–342, 10.1007/s40263-014-0152-8; https://pubmed.ncbi.nlm.nih.gov/24590663/
- Schrauzer, G. N., and K. P. Shrestha. “Lithium in Drinking Water and the Incidences of Crimes, Suicides, and Arrests Related to Drug Addictions.” Biological Trace Element Research, vol. 25, no. 2, 1 May 1990, pp. 105–113; 10.1007/BF02990271; https://pubmed.ncbi.nlm.nih.gov/1699579/
- Blüml, Victor, et al. “Lithium in the Public Water Supply and Suicide Mortality in Texas.” Journal of Psychiatric Research, vol. 47, no. 3, 1 Mar. 2013, pp. 407–411, 10.1016/j.jpsychires.2012.12.002; https://pubmed.ncbi.nlm.nih.gov/23312137/
- Ohgami, Hirochika, et al. “Lithium Levels in Drinking Water and Risk of Suicide.” The British Journal of Psychiatry: The Journal of Mental Science, vol. 194, no. 5, 1 May 2009, pp. 464–465; discussion 446, 10.1192/bjp.bp.108.055798; https://pubmed.ncbi.nlm.nih.gov/19407280/
- Zarse, Kim, et al. “Low-Dose Lithium Uptake Promotes Longevity in Humans and Metazoans.” European Journal of Nutrition, vol. 50, no. 5, 1 Aug. 2011, pp. 387–389, 10.1007/s00394-011-0171-x; https://pubmed.ncbi.nlm.nih.gov/21301855/
- Schrauzer, G. N., and E. de Vroey. “Effects of Nutritional Lithium Supplementation on Mood. A Placebo-Controlled Study with Former Drug Users.” Biological Trace Element Research, vol. 40, no. 1, 1 Jan. 1994, pp. 89–101, 10.1007/BF02916824; https://pubmed.ncbi.nlm.nih.gov/7511924/
- Sartori, H.E. “Lithium Orotate in the Treatment of Alcoholism and Related Conditions.” Alcohol, vol. 3, no. 2, Mar. 1986, pp. 97–100, 10.1016/0741-8329(86)90018-2; https://pubmed.ncbi.nlm.nih.gov/3718672/
- Terao, Takeshi, et al. “Even Very Low but Sustained Lithium Intake Can Prevent Suicide in the General Population?” Medical Hypotheses, vol. 73, no. 5, 1 Nov. 2009, pp. 811–812, 10.1016/j.mehy.2009.02.043; https://pubmed.ncbi.nlm.nih.gov/19457619/
- Wada, Akihiko. “Lithium and Neuropsychiatric Therapeutics: Neuroplasticity via Glycogen Synthase Kinase-3beta, Beta-Catenin, and Neurotrophin Cascades.” Journal of Pharmacological Sciences, vol. 110, no. 1, 1 May 2009, pp. 14–28, 10.1254/jphs.09r02cr; https://pubmed.ncbi.nlm.nih.gov/19423950/
- Kaidanovich-Beilin, Oksana, et al. “Rapid Antidepressive-like Activity of Specific Glycogen Synthase Kinase-3 Inhibitor and Its Effect on Beta-Catenin in Mouse Hippocampus.” Biological Psychiatry, vol. 55, no. 8, 15 Apr. 2004, pp. 781–784, 10.1016/j.biopsych.2004.01.008; https://pubmed.ncbi.nlm.nih.gov/15050857/
- Manji, H. K., et al. “Lithium at 50: Have the Neuroprotective Effects of This Unique Cation Been Overlooked?” Biological Psychiatry, vol. 46, no. 7, 1 Oct. 1999, pp. 929–940, 10.1016/s0006-3223(99)00165-1; https://pubmed.ncbi.nlm.nih.gov/10509176/
- Sanders LM, Zeisel SH; “Choline: Dietary Requirements and Role in Brain Development;” Nutrition today; 2007;42(4):181-186; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518394/
- Purves D, Augustine GJ, Fitzpatrick D, et al.; “Neuroscience;” 2nd edition. Sunderland (MA): Sinauer Associates; 2001. Acetylcholine. https://www.ncbi.nlm.nih.gov/books/NBK11143/
- Hasselmo ME; “The role of acetylcholine in learning and memory;”Curr Opin Neurobiol. 2006;16(6):710–715; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659740/
- Jones BE; “From waking to sleeping: neuronal and chemical substrates”. Trends Pharmacol. Sci.; 2005; 26 (11): 578–86; https://www.ncbi.nlm.nih.gov/pubmed/16183137
- Ueland, P. M.; “Choline and betaine in health and disease;” Journal of Inherited Metabolic Disease; 2010; 34(1), 3–15; https://onlinelibrary.wiley.com/doi/abs/10.1007/s10545-010-9088-4
- Marcus L, et al; “Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance;” J Int Soc Sports Nutr; 2017;14:39; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629791/
- Bellar D, LeBlanc NR, Campbell B; “The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength”; J Int Soc Sports Nutr. 2015; 12(1):42; http://www.jissn.com/content/12/1/42
- Ziegenfuss T, Landis J, Hofheins J. Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. Journal of the International Society of Sports Nutrition. 2008;5(Suppl 1):P15. doi:10.1186/1550-2783-5-S1-P15; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313098/
- De Jesus Moreno Moreno M; Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial . Clin Ther. (2003); https://linkinghub.elsevier.com/retrieve/pii/S0149291803900233
- Parnetti L, Amenta F, Gallai V; Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data . Mech Ageing Dev. (2001); https://linkinghub.elsevier.com/retrieve/pii/S0047637401003128
- Secades, JJ; “Citicoline: pharmacological and clinical review, 2016 update;” Rev Neurol; 2017; https://www.researchgate.net/profile/Julio_Secades/publication/317167480_Citicoline_pharmacological_and_clinical_review_2016_update/links/59280785a6fdcc444353790e/Citicoline-pharmacological-and-clinical-review-2016-update.pdf
- Karlic, Heidrun, and Alfred Lohninger. “Supplementation of L-Carnitine in Athletes: Does It Make Sense?” Nutrition, vol. 20, no. 7-8, July 2004, pp. 709–715, 10.1016/j.nut.2004.04.003; https://pubmed.ncbi.nlm.nih.gov/15212755/
- Lombard, K A, et al. “Carnitine Status of Lactoovovegetarians and Strict Vegetarian Adults and Children.” The American Journal of Clinical Nutrition, vol. 50, no. 2, 1 Aug. 1989, pp. 301–306, 10.1093/ajcn/50.2.301; https://pubmed.ncbi.nlm.nih.gov/2756917/
- Novakova, Katerina, et al. “Effect of L-Carnitine Supplementation on the Body Carnitine Pool, Skeletal Muscle Energy Metabolism and Physical Performance in Male Vegetarians.” European Journal of Nutrition, vol. 55, no. 1, 23 Jan. 2015, pp. 207–217, 10.1007/s00394-015-0838-9; https://pubmed.ncbi.nlm.nih.gov/25612929/
- Parnetti, L, et al; “Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type”; Eur J Clin Pharmacol. 1992; 42(1):89-93; https://www.ncbi.nlm.nih.gov/pubmed/1541322
- Chacko SM, Thambi PT, Kuttan R, Nishigaki I; “Beneficial effects of green tea: a literature review”; Chin Med.; 2010; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855614/
- Harada, Ushio, et al. “Effects of the Long-Term Ingestion of Tea Catechins on Energy Expenditure and Dietary Fat Oxidation in Healthy Subjects.” Journal of Health Science, vol. 51, no. 2, 2005, pp. 248–252, 10.1248/jhs.51.248; https://www.jstage.jst.go.jp/article/jhs/51/2/51_2_248/_pdf/-char/en
- Wang Y, Yang Z, Wei X; “Sugar compositions, α-glucosidase inhibitory and amylase inhibitory activities of polysaccharides from leaves and flowers of Camellia sinensis obtained by different extraction methods”; Int J Biol Macromol; 2010; https://pubmed.ncbi.nlm.nih.gov/20678520/
- Fielding, Roger, et al. “L-Carnitine Supplementation in Recovery after Exercise.” Nutrients, vol. 10, no. 3, 13 Mar. 2018, p. 349, 10.3390/nu10030349; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872767/
- Nakashima, A., et al. “Role of N-Terminus of Tyrosine Hydroxylase in the Biosynthesis of Catecholamines.” Journal of Neural Transmission (Vienna, Austria: 1996), vol. 116, no. 11, 1 Nov. 2009, pp. 1355–1362, 10.1007/s00702-009-0227-8; https://pubmed.ncbi.nlm.nih.gov/19396395/
- Attipoe, S., et al. July 2015. “Tyrosine for Mitigating Stress and Enhancing Performance in Healthy Adult Humans, a Rapid Evidence Assessment of the Literature.” Military Medicine vol. 180, 7. 754-65. https://academic.oup.com/milmed/article/180/7/754/4160625#101253256
- Roberto, Mike; “L-Tyrosine vs. N-Acetyl L-Tyrosine: A Tale of Two Tyrosines”; The PricePlow Blog; May 26, 2017; https://blog.priceplow.com/nootropics/l-tyrosine
- Mannucci, C et al. “Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 19,12 (2012): 1117-24. doi:10.1016/j.phymed.2012.07.001; https://pubmed.ncbi.nlm.nih.gov/22921986/
- Darbinyan, V et al. “Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.” Nordic journal of psychiatry vol. 61,5 (2007): 343-8. doi:10.1080/08039480701643290; https://pubmed.ncbi.nlm.nih.gov/17990195/
- Dimpfel, Wilfried et al. “Assessing the Quality and Potential Efficacy of Commercial Extracts of Rhodiola rosea L. by Analyzing the Salidroside and Rosavin Content and the Electrophysiological Activity in Hippocampal Long-Term Potentiation, a Synaptic Model of Memory.” Frontiers in pharmacology vol. 9 425. 24 May. 2018, doi:10.3389/fphar.2018.00425; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976749/
- Cropley, Mark et al. “The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms.” Phytotherapy research : PTR vol. 29,12 (2015): 1934-9. doi:10.1002/ptr.5486; https://pubmed.ncbi.nlm.nih.gov/26502953/
- Edwards, D et al. “Therapeutic effects and safety of Rhodiola rosea extract WS 1375 in subjects with life-stress symptoms–results of an open-label study.” Phytotherapy research : PTR vol. 26,8 (2012): 1220-5. doi:10.1002/ptr.3712; https://pubmed.ncbi.nlm.nih.gov/22228617/
- Spasov, A A et al. “A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 7,2 (2000): 85-9. doi:10.1016/S0944-7113(00)80078-1; https://pubmed.ncbi.nlm.nih.gov/10839209/
- Shevtsov, V A et al. “A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 10,2-3 (2003): 95-105. doi:10.1078/094471103321659780; https://pubmed.ncbi.nlm.nih.gov/12725561/
- van Diermen, Daphne et al. “Monoamine oxidase inhibition by Rhodiola rosea L. roots.” Journal of ethnopharmacology vol. 122,2 (2009): 397-401. doi:10.1016/j.jep.2009.01.007. https://pubmed.ncbi.nlm.nih.gov/19168123/
- Zhong, Zhi-feng, et al. “Neuroprotective Effects of Salidroside on Cerebral Ischemia/Reperfusion-Induced Behavioral Impairment Involves the Dopaminergic System.” Frontiers in Pharmacology, 13 Dec. 2019. https://www.frontiersin.org/articles/10.3389/fphar.2019.01433/full
- Roberto, Mike; “Alpha Lipoic Acid (ALA): The Cognitive-Boosting Antioxidant”; The PricePlow Blog; February 3, 2020; https://blog.priceplow.com/supplement-research/alpha-lipoic-acid
- Kleinkauf-Rocha, J., Bobermin, L. D., Machado, P. de M., Gonçalves, C.-A., Gottfried, C., & Quincozes-Santos, A. (2013). Lipoic acid increases glutamate uptake, glutamine synthetase activity and glutathione content in C6 astrocyte cell line. International Journal of Developmental Neuroscience, 31(3), 165–170.https://www.ncbi.nlm.nih.gov/pubmed/23286972
- Wang, S.-J., & Chen, H.-H. (2007). Presynaptic mechanisms underlying the α-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals. Neurochemistry International, 50(1), 51–60.https://www.sciencedirect.com/science/article/pii/S0197018606002385
- Santos, P. S., Campêlo, L. M. L., Freitas, R. L. M., Feitosa, C. M., Saldanha, G. B., & Freitas, R. M. (2011). Lipoic acid effects on glutamate and taurine concentrations in rat hippocampus after pilocarpine-induced seizures. Arquivos de Neuro-Psiquiatria, 69(2b), 360–364. https://www.ncbi.nlm.nih.gov/pubmed/21625766
- Gupte, A. A., Bomhoff, G. L., Morris, J. K., Gorres, B. K., & Geiger, P. C. (2009). Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats. Journal of Applied Physiology, 106(4), 1425–1434. https://www.ncbi.nlm.nih.gov/pubmed/19179648
- Freitas, R. M., Jordán, J., & Feng, D. (2010). Lipoic acid effects on monoaminergic system after pilocarpine-induced seizures. Neuroscience Letters, 477(3), 129–133. https://www.ncbi.nlm.nih.gov/pubmed/20433896
- Crook, T., et al. “Effects of Phosphatidylserine in Alzheimer’s Disease.” Psychopharmacology Bulletin, vol. 28, no. 1, 1992, pp. 61–66; http://www.ncbi.nlm.nih.gov/pubmed/1609044
- Klinkhammer, P., et al. “Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer’s Disease.” Dementia and Geriatric Cognitive Disorders, vol. 1, no. 4, 1990, pp. 197–201, 10.1159/000107142; https://www.karger.com/Article/Abstract/107142
- Kato-Kataoka, Akito, et al. “Soybean-Derived Phosphatidylserine Improves Memory Function of the Elderly Japanese Subjects with Memory Complaints.” Journal of Clinical Biochemistry and Nutrition, vol. 47, no. 3, 2010, pp. 246–255; 10.3164/jcbn.10-62; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966935/
- Engel, Rolf R., et al. “Double-Blind Cross-over Study of Phosphatidylserine vs. Placebo in Patients with Early Dementia of the Alzheimer Type.” European Neuropsychopharmacology, vol. 2, no. 2, June 1992, pp. 149–155, 10.1016/0924-977x(92)90025-4; https://pubmed.ncbi.nlm.nih.gov/1633433/
- Baumeister, J., et al. “Influence of Phosphatidylserine on Cognitive Performance and Cortical Activity after Induced Stress.” Nutritional Neuroscience, vol. 11, no. 3, June 2008, pp. 103–110, 10.1179/147683008×301478; https://pubmed.ncbi.nlm.nih.gov/18616866/
- Monteleone, P., et al. “Blunting by Chronic Phosphatidylserine Administration of the Stress-Induced Activation of the Hypothalamo-Pituitary-Adrenal Axis in Healthy Men.” European Journal of Clinical Pharmacology, vol. 42, no. 4, 1992, pp. 385–388, 10.1007/bf00280123; https://pubmed.ncbi.nlm.nih.gov/1325348/
- Kingsley, M, et al; “Effects of phosphatidylserine on exercise capacity during cycling in active males”; Medicine and Science in Sports and Exercise; 38(1):64-71; 2006 Jan; https://www.ncbi.nlm.nih.gov/pubmed/16394955
- Georgiadou, G., et al. “Effects of the Active Constituents of Crocus Sativus L., Crocins, in an Animal Model of Obsessive-Compulsive Disorder.” Neuroscience Letters, vol. 528, no. 1, 18 Oct. 2012, pp. 27–30, 10.1016/j.neulet.2012.08.081; https://pubmed.ncbi.nlm.nih.gov/22985509/
- Akhondzadeh Basti, Afshin, et al. “Comparison of Petal of Crocus Sativus L. And Fluoxetine in the Treatment of Depressed Outpatients: A Pilot Double-Blind Randomized Trial.” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 2, Mar. 2007, pp. 439–442, 10.1016/j.pnpbp.2006.11.010; https://pubmed.ncbi.nlm.nih.gov/17174460/
- Akhondzadeh, Shahin, et al. “Comparison of Crocus Sativus L. And Imipramine in the Treatment of Mild to Moderate Depression: A Pilot Double-Blind Randomized Trial [ISRCTN45683816].” BMC Complementary and Alternative Medicine, vol. 4, no. 1, 2 Sept. 2004; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC517724/
- Moshiri, Esmail, et al. “Crocus Sativus L. (Petal) in the Treatment of Mild-To-Moderate Depression: A Double-Blind, Randomized and Placebo-Controlled Trial.” Phytomedicine, vol. 13, no. 9-10, Nov. 2006, pp. 607–611, 10.1016/j.phymed.2006.08.006; https://pubmed.ncbi.nlm.nih.gov/16979327/
- Agha-Hosseini, M., et al. “Crocus Sativus L. (Saffron) in the Treatment of Premenstrual Syndrome: A Double-Blind, Randomised and Placebo-Controlled Trial.” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 115, no. 4, 1 Mar. 2008, pp. 515–519; 10.1111/j.1471-0528.2007.01652.x; https://pubmed.ncbi.nlm.nih.gov/18271889/
- Akhondzadeh, Shahin, et al. “Crocus Sativus L. In the Treatment of Mild to Moderate Depression: A Double-Blind, Randomized and Placebo-Controlled Trial.” Phytotherapy Research, vol. 19, no. 2, 2005, pp. 148–151, 10.1002/ptr.1647; https://pubmed.ncbi.nlm.nih.gov/15852492/
- Nakano, Masahiko, et al; “Effects of Antioxidant Supplements (BioPQQ) on Cerebral Blood Flow and Oxygen Metabolism in the Prefrontal Cortex.”; Advances in Experimental Medicine and Biology; U.S. National Library of Medicine; 2016; https://www.ncbi.nlm.nih.gov/pubmed/27526146
- Saihara K, Kamikubo R, Ikemoto K, Uchida K, Akagawa M; “Pyrroloquinoline Quinone, a Redox-Active o‑Quinone, Stimulates Mitochondrial Biogenesis by Activating the SIRT1PGC-1α Signaling Pathway”; Biochemistry; 2017; 56; 6615−6625; https://pubs.acs.org/doi/10.1021/acs.biochem.7b01185
- Harris, Calliandra B, et al; “Dietary Pyrroloquinoline Quinone (PQQ) Alters Indicators of Inflammation and Mitochondrial-Related Metabolism in Human Subjects.”; The Journal of Nutritional Biochemistry; U.S. National Library of Medicine; Dec. 2013; https://www.ncbi.nlm.nih.gov/pubmed/24231099
- Nakano, M., et al; “Effect of Oral Supplementation with Pyrroloquinoline Quinone on Stress, Fatigue, and Sleep.”; Functional Foods in Health and Disease; 2012; 2(8); 307-324; https://www.functionalfoodscenter.net/files/56592277.pdf